Cardiovascular Revascularization Medicine
Volume 9, Issue 4 , Pages 218-223, October 2008

Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents

  • James A. Shaw

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute, Melbourne, Australia
    • Corresponding Author InformationCorrresponding author. Department of Cardiology Alfred Hospital and Baker Heart Research Institute, Commercial Rd, Melbourne, Australia. Tel.: +61 3 9076 3321; fax: +61 3 90762461.
    • ,
  • Nick Andrianopoulos

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Stephen Duffy

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Baker Heart Research Institute, Melbourne, Australia
    • ,
  • Anthony S. Walton

      Affiliations

    • Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    • Department of Cardiology of The Western Hospital, Melbourne, Australia
    • ,
  • David Clark

      Affiliations

    • Department of Cardiology of The Austin Hospital, Melbourne, Australia
    • ,
  • Robert Lew

      Affiliations

    • Department of Cardiology of The Frankston Hospital, Melbourne, Australia
    • ,
  • Martin Sebastian

      Affiliations

    • Department of Cardiology of The Geelong Hospital, Melbourne, Australia
    • ,
  • Gishel New

      Affiliations

    • Department of Cardiology of The Box Hill Hospital, Melbourne, Australia
    • ,
  • Angela Brennan

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Chris Reid

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • ,
  • Andrew E. Ajani

      Affiliations

    • Department of Epidemiology and Preventive Medicine, NHMRC Center of Clinical Research Excellence in Therapeutics, Monash University, Melbourne, Australia
    • Department of Cardiology of The Royal Melbourne Hospital, Melbourne, Australia
    • University of Melbourne, Melbourne, Australia
    • ,
  • On behalf of the Melbourne Interventional Group

Received 21 January 2008; received in revised form 6 May 2008; accepted 8 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1553-8389(08)00210-8

doi:10.1016/j.carrev.2008.05.002

Cardiovascular Revascularization Medicine
Volume 9, Issue 4 , Pages 218-223, October 2008

Article Tools

* Image Usage & Resolution